The estimated Net Worth of James Edward Machek is at least $214 Mille dollars as of 1 June 2016. James Machek owns over 957 units of Endologix stock worth over $8,423 and over the last 11 years James sold ELGX stock worth over $205,688.
James has made over 5 trades of the Endologix stock since 2015, according to the Form 4 filled with the SEC. Most recently James sold 957 units of ELGX stock worth $12,010 on 1 June 2016.
The largest trade James's ever made was selling 6,500 units of Endologix stock on 26 May 2016 worth over $82,940. On average, James trades about 1,010 units every 19 days since 2013. As of 1 June 2016 James still owns at least 38,286 units of Endologix stock.
You can see the complete history of James Machek stock trades at the bottom of the page.
James's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott e Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: